纳斯达克生物科技类股多数收跌，Gritstone Oncology（GRTS）跌超42.4%，该公司称其Coral samRNA疫苗在研究中表现出很好的耐受性；AVROBIO（AVRO）跌超36.6%，Intra-Cellular Therapies（ITCI）跌超14.1%，Prelude跌超13.5%，Iteos跌约11.5%，Veracyte跌超11.2%，Maravai Lifesciences、SilverBack、Rallybio、89Bio、Codexis、Singular Genomics Systems、Spectrum Pharmaceuticals至少跌超10.0%，Reata Pharmaceuticals则涨超9.0%，EyePoint Pharmaceuticals涨超9.9%，TherapeuticsMD涨约11.2%。